ESTRO Brachytherapy for Prostate Cancer 2018

740 / 884

Study CLIN1001 PCM301
A european randomised phase III study to evaluate the
effect and safety of TOOKAD ® Soluble
In localized prostate cancer in comparison with active
surveillance.